NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study) [Clinical Sciences]

Conclusions—CEST is safe among unselected ischemic stroke patients with or without a visible occlusion on computed tomography angiography and with varying grades of clinical severity. There was, however, statistically no significant clinical effect of sonothrombolysis in this prematurely stopped trial.Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01949961.

Source: Stroke - January 22, 2017 Category: Neurology Authors: Aliona Nacu, Christopher E. Kvistad, Halvor Naess, Halvor Oygarden, Nicola Logallo, Jorg Assmus, Ulrike Waȷe–Andreassen, Kathinka D. Kurz, Gesche Neckelmann, Lars Thomassen Tags: Clinical Studies, Ischemia, Cerebrovascular Disease/Stroke, Ischemic Stroke Original Contributions Source Type: research